In contrast, factors like ATL3 (Log2 ratio 1.40), ERGIC1 (Log2 ratio 1.64), SPON1 (Log2 ratio 1.25), TNFAIP8 (Log2 ratio 1.99), and VDAC1 (Log2 ratio 1.20), associated with a “highly favorable” prognosis, suggest roles in tumor suppression. This evidence concerns the gene ERGIC1 and neoplasm.